Cetera Advisors’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$289K Buy
2,593
+688
+36% +$82K ﹤0.01% 1964
2023
Q4
$247K Sell
1,905
-1,639
-46% -$226K ﹤0.01% 1526
2023
Q3
$578K Buy
3,544
+1,909
+117% +$336K 0.01% 982
2023
Q2
$300K Buy
+1,635
New +$235K ﹤0.01% 1313

Other funds holding ACLS

Cetera Advisors's ACLS Position: Q1 2024 in Review

Cetera Advisors increased its Axcelis (ACLS) stake by 36% in Q1 2024, buying an estimated $82K and bringing the position to 2,593 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #1964.

Cetera Advisors first reported a position in ACLS in Q2 2023 and has held it in 4 quarters since. The position peaked at $578K in Q3 2023. 385 funds tracked by Wall St. Rank hold ACLS as of Q1 2024.

  • Cetera Advisors held 2,593 shares of Axcelis worth $289K as of Q1 2024.
  • Cetera Advisors bought 688 Axcelis shares in Q1 2024, an estimated $82K.
  • Axcelis made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #1964 holding.
  • Cetera Advisors first reported a position in Axcelis in Q2 2023 and has held it in 4 quarters since.
  • Cetera Advisors's Axcelis position peaked at $578K in Q3 2023.
  • 385 funds tracked by Wall St. Rank held Axcelis as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.